NADPH Oxidases, Angiogenesis, and Peripheral Artery Disease
AbstractPeripheral artery disease (PAD) is caused by narrowing of arteries in the limbs, normally occurring in the lower extremities, with severe cases resulting in amputation of the foot or leg. A potential approach for treatment is to stimulate the formation of new blood vessels to restore blood flow to limb tissues. This is a process called angiogenesis and involves the proliferation, migration, and differentiation of endothelial cells. Angiogenesis can be stimulated by reactive oxygen species (ROS), with NADPH oxidases (NOX) being a major source of ROS in endothelial cells. This review summarizes the recent evidence implicating NOX isoforms in their ability to regulate angiogenesis in vascular endothelial cells in vitro, and in PAD in vivo. Increasing our understanding of the involvement of the NOX isoforms in promoting therapeutic angiogenesis may lead to new treatment options to slow or reverse PAD. View Full-Text
Share & Cite This Article
Manuneedhi Cholan, P.; Cartland, S.P.; Kavurma, M.M. NADPH Oxidases, Angiogenesis, and Peripheral Artery Disease. Antioxidants 2017, 6, 56.
Manuneedhi Cholan P, Cartland SP, Kavurma MM. NADPH Oxidases, Angiogenesis, and Peripheral Artery Disease. Antioxidants. 2017; 6(3):56.Chicago/Turabian Style
Manuneedhi Cholan, Pradeep; Cartland, Siân P.; Kavurma, Mary M. 2017. "NADPH Oxidases, Angiogenesis, and Peripheral Artery Disease." Antioxidants 6, no. 3: 56.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.